Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Journal: Blood advances
Year: May 08, 2023
Hematologist-Oncologist
5
No OPD information available
Marginal Zone Lymphoma (MZL)
B-Cell Lymphoma
Deep Vein Thrombosis
Hemolytic Transfusion Reaction
Hypothermia
Mesenteric Venous Thrombosis
Protein C Deficiency
Venous Thromboembolism (VTE)
Magdalena Teague-Sobieraj is a female healthcare professional who helps patients with different health issues. Some of the conditions she specializes in are Marginal Zone Lymphoma, B-Cell Lymphoma, Deep Vein Thrombosis, Hemolytic Transfusion Reaction, Hypothermia, Mesenteric Venous Thrombosis, Protein C Deficiency, and Venous Thromboembolism.
Magdalena Teague-Sobieraj uses her special skills and knowledge to treat patients with care and expertise. She is good at explaining medical information in a way that patients can understand, which helps them feel more comfortable and confident in their treatment.
Patients trust Magdalena Teague-Sobieraj because she listens to their concerns, answers their questions, and involves them in decisions about their health. She shows empathy and compassion, making patients feel supported and cared for during their medical journey.
To stay updated with the latest medical knowledge and research, Magdalena Teague-Sobieraj regularly attends conferences, reads medical journals, and participates in continuing education programs. This helps her provide the best and most up-to-date care for her patients.
Magdalena Teague-Sobieraj works well with her colleagues and other medical professionals. She values collaboration and teamwork, which leads to better outcomes for patients. By sharing knowledge and expertise with others, she contributes to a positive and supportive work environment.
Through her work, Magdalena Teague-Sobieraj has positively impacted many patients' lives. Her dedication to providing high-quality care and her commitment to ongoing learning have helped patients improve their health and well-being.
One of Magdalena Teague-Sobieraj's notable publications is a study on the safety and efficacy of a treatment for Marginal Zone Lymphoma. She has also been involved in clinical trials to advance medical knowledge and improve treatment options for patients with this condition.
Journal: Blood advances
Year: May 08, 2023
Enrollment Status: Completed
Published: October 26, 2024
Intervention Type: Drug
Study Drug: Zanubrutinib
Study Phase: Phase 2
Dr. Teague-Sobieraj is a caring and knowledgeable Hematologist-Oncologist. She explained everything clearly and made me feel at ease during my appointments. Highly recommend!
I am grateful for the excellent care I received from Dr. Teague-Sobieraj. She is compassionate and dedicated to her patients' well-being. Thank you for everything!
Dr. Teague-Sobieraj is a fantastic Hematologist-Oncologist. She took the time to listen to my concerns and provided thorough explanations. I feel confident in her expertise.
I had a positive experience with Dr. Teague-Sobieraj. She is professional, kind, and truly cares about her patients. Thank you for your exceptional care!
Dr. Teague-Sobieraj is an outstanding Hematologist-Oncologist. She is attentive, supportive, and goes above and beyond to ensure the best possible outcomes for her patients. Highly recommended!